Pressure BioSciences has launched a commercial biopharmaceutical contract service business after acquiring a protein therapeutics platform that it says reduces challenges and manufacturing costs of the growing drug market.
The 5,000-square-foot expansion responds to client demand, says president Robert Lee: “The market for services is growing, yet the supply of CMOs interested in taking on these complex drug products is not.”
Pfizer CentreOne has recently expanded its fill-finish and highly potent solid oral dose service offerings at two of its contract manufacturing facilities as it aims to fulfill a promise to grow its capabilities.
Overcapacity in pharmaceutical manufacturing around the world means that smaller drugmakers sometimes set themselves up as contract manufacturers in order to provide an additional revenue stream and avoid standing plants idle.
Sancilio & Co (SCI) says that its new contract manufacturing plant in Riviera Beach, Florida can provide pharmaceutical manufacturers with small batch production capacity for drug tablets and capsules.
Offshoring contract manufacturing is not the only option for large
pharma firms looking to drive productivity and efficiency gains in
drug manufacturing, warns a new report from independent market
Despite its consolidation, the competitive consumable sector still
offers potential for rapid growth and better profits in the
biopharmaceutical industry, while contract bioprocessing services
will be increasingly in demand, according...
Oman Pharmaceutical Products (OPP) has entered its first
outsourcing partnership in Europe with Finnish company
Dragenopharm, providing the first step in its strategy to offer
contract manufacturing services globally.
Pharmaceutical companies are increasingly looking to retain their
internal focus on research and development (R&D) and marketing
while outsourcing their manufacturing processes, thus fueling a
growing demand for the manufacturing...
A desire by pharmaceutical companies to concentrate their resources
on marketing products, rather than production and drug discovery,
will drive global revenues for contract manufacturing and research
to nearly $168bn (€128bn) by...
Medivative Technologies, a contract manufacturing and process
engineering services supplier to the life sciences and medical
device industries, has just been cleared for operations by the US
Food and Drug Administration (FDA).
Japan's Sumitomo Chemical is absorbing its wholly-owned Sumika Fine
Chemicals subsidiary and combining it with its own activities in
this area to bolster its role as a supplier of pharmaceutical